Worldwide, tobacco smoke is still the leading cause of preventable morbidity and mortality. Many smokers develop chronic smoking-related conditions that require emergency department (ED) visits. However, best practices for ED smoking cessation counselling are still unclear.

A randomized controlled trial was conducted to determine whether an “ask, advise, and refer” approach increases 12-month, 30-day quit rates in the stable adult ED smoking population compared to usual care. Patients in the intervention group were referred to a community counselling service that offers a quitline, a text-based program, and a Web-based program. Longitudinal intention-to-treat analyses were performed.

From November 2011 to March 2013, 1,295 patients were enrolled from one academic tertiary care ED. Six hundred thirty-five were allocated to usual care, and 660 were allocated to intervention. Follow-up data were available for 70% of all patients at 12 months. There was no statistically significant difference in 12-month, 30-day quit rates between the two groups. However, there was a trend towards higher 7-day quit attempts, 7-day quit rates, and 30-day quit rates at 3, 6, and 12 months in the intervention group.

In this study, there was a trend towards increased smoking cessation following referral to a community counselling service. There was no statistically significant difference. However, if ED smoking cessation efforts were to provide even a small positive effect, such an intervention may have a significant public health impact given the extensive reach of emergency physicians.

Patients who are tobacco users present to the emergency department (ED) with many medical conditions that are causally or potentially causally related to smoking. Previous studies have shown increased cessation rates for patients who accurately perceive that their ED visit is smoking-related. Our study goals were 1) to determine the prevalence of potential smoking-related conditions among tobacco users at a tertiary care academic ED, and 2) to determine which medical conditions are more or less likely to be perceived by patients as smoking-related.

We included adults≥19 years of age who reported smoking within 30 days of their ED visit, and were enrolled in a randomized controlled trial (ClinicalTrials.gov, NCT01454375) from December 1, 2011 to August 31, 2012. Patients were asked whether they perceived their ED visit to be related to smoking. ED discharge diagnoses were coded as smoking-related or not smoking-related based on the 2004 U.S. Surgeon General’s Report.

We included 893 patients (62% male; mean age=40±15), of which 120 (13%) had a visit for a potential smoking-related condition: 6 (5%) of neoplasm, 18 (15%) of cardiovascular disease, 67 (56%) of respiratory disease, 3 (3%) of reproductive complication, 7 (6%) of postoperative complication, 9 (8%) of dental disease, 9 (8%) of peptic ulcer disease, 0 (0%) of eye condition, and 1 (1%) of bony condition. Of the potential smoking-related conditions, 46 (38%) were perceived by patients to be possibly smoking-related: 61% of cardiovascular disease, 33% of neoplasm, 43% of respiratory disease, 22% of dental disease, 14% of postoperative complication, 11% of peptic ulcer disease, and 0% of the remaining conditions.

In this study, 13% of all ED visits among smokers were for a potential smoking-related condition, of which 38% were perceived by patients to be smoking-related. Education to increase awareness of smoking-related conditions may increase cessation rates.